Health CareMedical Equipment and Services
  • Price (USD)126.38
  • Today's Change5.04 / 4.15%
  • Shares traded1.34m
  • 1 Year change-18.98%
  • Beta1.0536
Data delayed at least 15 minutes, as of Oct 03 2022 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business provides application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics business includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. Its Agilent CrossLab business spans the entire lab with its range of services portfolio, which is designed to improve customer outcomes. Its product categories include liquid chromatography (LC) systems and components, atomic absorption (AA) instruments and others.

  • Revenue in USD (TTM)6.66bn
  • Net income in USD1.33bn
  • Incorporated1999
  • Employees17.70k
  • Location
    Agilent Technologies Inc5301 Stevens Creek BlvdSANTA CLARA 95051United StatesUSA
  • Phone+1 (408) 345-8296
  • Fax+1 (408) 345-8474
  • Websitehttps://www.agilent.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
A:NYQ since
PSS Polymer Standards Service GmbHDeal completed02 Aug 202202 Aug 2022Deal completed-5.28%--
Data delayed at least 15 minutes, as of Oct 03 2022 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Fortive Corp5.52bn658.60m21.06bn18.00k32.662.2319.233.821.811.8015.1826.560.36094.546.27306,422.204.315.235.196.4157.3955.0011.9415.080.72679.600.280414.0613.38-0.4635-58.09-4.77-14.6014.87
Mettler-Toledo International Inc.3.87bn820.63m25.16bn15.60k31.493,464.4826.986.5135.4935.49167.190.32271.193.966.30247,779.9025.3321.4337.1130.0758.3258.0021.2318.720.770122.370.99630.0020.518.1927.5814.88-2.79--
AMETEK, Inc.5.92bn1.09bn26.10bn18.50k24.173.7518.624.414.704.7025.4430.270.49854.616.50319,865.009.228.8410.8010.2034.6236.2018.4916.730.884917.510.264716.8822.177.6313.4814.0911.8317.32
Keysight Technologies Inc5.27bn1.11bn27.81bn14.70k25.807.1220.885.286.036.0328.6921.860.67342.366.76368,601.4014.147.6816.849.2564.0758.1721.0011.732.3818.390.31370.0017.0611.1142.5821.6913.84--
Illumina, Inc.4.69bn-20.00m28.93bn9.80k--2.7790.676.16-0.0815-0.081529.9866.520.3893.397.82478,775.50-0.165810.93-0.196412.9667.5468.81-0.426323.160.8237--0.14280.0039.7313.5416.1610.49-5.15--
Agilent Technologies Inc6.66bn1.33bn36.21bn17.70k27.907.1121.875.444.384.3822.0117.200.6353.345.40391,705.9012.6610.0515.3111.9954.2153.9519.9417.371.4120.830.363922.5218.368.5068.2921.246.3411.36
Roper Technologies Inc5.57bn921.10m39.97bn19.30k43.712.9125.917.188.6326.8452.13129.480.226311.426.14288,378.303.755.664.236.4168.6865.4816.5520.411.557.300.35219.2019.038.8019.038.339.3113.40
Emerson Electric Co.19.22bn3.16bn43.25bn86.70k13.834.2010.382.255.295.2932.1517.420.62475.125.10221,637.8010.399.7215.9713.5840.9442.1316.6312.030.8007--0.415859.588.644.6617.207.695.381.23
Data as of Oct 03 2022. Currency figures normalised to Agilent Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

36.87%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202223.46m7.85%
BlackRock Fund Advisorsas of 30 Jun 202217.23m5.77%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 202216.65m5.58%
SSgA Funds Management, Inc.as of 30 Jun 202213.08m4.38%
Wellington Management Co. LLPas of 30 Jun 202212.53m4.20%
Massachusetts Financial Services Co.as of 30 Jun 20225.85m1.96%
Geode Capital Management LLCas of 30 Jun 20225.84m1.95%
BlackRock Investment Management (UK) Ltd.as of 30 Jun 20225.79m1.94%
Pictet Asset Management SAas of 30 Jun 20225.48m1.83%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 20224.21m1.41%
More ▼
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.